Role of EZH2 in bone marrow mesenchymal stem cells and immune-cancer interactions.

Zhaoyun Liu, Yue Jia, Yixuan Guo, Hao Wang, Rong Fu

Critical reviews in oncology/hematology 2022 Jan

filter terms:

In recent years, methylation modification has been determined to be vital for the biological regulation of normal cells, tumor cells, and tumor microenvironment immune cells. Enhancer of zeste homology 2 (EZH2), a component of the Polycomb Repressive Complex 2 (PRC2), catalyzes the trimethylation of the downstream gene in the tri-methylates histone three lysine 27 (H3K27me3) position, which causes chromatin pyknosis, and thus, silences the expression of related genes. In this paper, we reviewed the role of EZH2 in regulating bone marrow mesenchymal stem cell differentiation and the immune cell function in tumor microenvironment, summarized all types of existing EZH2 inhibitors and the main clinical trials, and proposed relevant ideas for potential clinical applications. Copyright © 2021. Published by Elsevier B.V.

Citation

Zhaoyun Liu, Yue Jia, Yixuan Guo, Hao Wang, Rong Fu. Role of EZH2 in bone marrow mesenchymal stem cells and immune-cancer interactions. Critical reviews in oncology/hematology. 2022 Jan;169:103547